header logo image


Page 1,091«..1020..1,0901,0911,0921,093..1,1001,110..»

Generic Viagra (Sildenafil Citrate) – Gesundheit Des …

September 13th, 2016 5:46 pm

Viagra is often the first treatment tried for erectile dysfunction in men and pulmonary arterial hypertension.

Package

Price

Per Pills

Savings

Order

25 mg x 10 pills

$25.99

$2.58

$0.00

25 mg x 20 pills

$43.99

$2.21

$7.40

25 mg x 30 pills

$57.99

$1.92

$19.80

25 mg x 60 pills

$98.99

$1.65

$55.80

25 mg x 90 pills

$132.99

$1.48

$99.00

25 mg x 120 pills

$159.99

$1.33

$150.00

25 mg x 180 pills

$201.99

$1.12

$262.80

25 mg x 270 pills

$272.99

$1.01

$423.90

Package

Price

Per Pills

Savings

Order

50 mg x 10 pills

$26.99

$2.72

$0.00

50 mg x 20 pills

$43.99

$2.18

$10.80

50 mg x 30 pills

$61.99

$2.06

$19.80

50 mg x 60 pills

$96.99

$1.62

$66.00

50 mg x 90 pills

$129.99

$1.44

$115.20

50 mg x 120 pills

$155.99

$1.30

$170.40

50 mg x 180 pills

$202.99

$1.13

$286.20

50 mg x 270 pills

$264.99

$0.98

$469.80

50 mg x 360 pills

$330.99

$0.92

$648.00

Package

Price

Per Pills

Savings

Order

100 mg x 10 pills

$35.99

$3.56

$0.00

100 mg x 20 pills

$58.99

$2.97

$11.80

100 mg x 30 pills

$80.99

$2.71

$25.50

100 mg x 60 pills

$113.99

$1.90

$99.60

Read the rest here:
Generic Viagra (Sildenafil Citrate) - Gesundheit Des ...

Read More...

Emory Eye Center

September 12th, 2016 8:49 pm

Sept. 12, 2016 | Emory Eye Center to Host Education Program for Pediatric Ophthalmologists. Pediatric ophthalmologists and other ophthalmic subspecialists will come together Sept. 16-17, 2016, for an opportunity to learn more about pediatric ophthalmology and to share cases from their own practices. The gathering, known as the Pediatric Ophthalmology and Strabismus Meeting of the Southeast (POSMS), will be sponsored by the Emory Eye Center and Emory University School of Medicine's Ophthalmology Department.

Sept. 1, 2016 | Emory Eye Center Again Earns a Spot inU.S. News & World Report's Healthcare Rankings. (ATLANTA) Emory Eye Center is again noted as a top ophthalmology center in the United States, according to the prestigious U.S. News & World Report guide to Americas top medical institutions.

August 26, 2016 | $3,023,456 Five-Year Award Announced by NEI for Emory Eye Center Vision Research. (ATLANTA) Emory Eye Center Director of Research P. Michael Iuvone, PhD, and his colleagues announced today the news of a first-year funding award of $624,000 for their P30 Core Grant for Vision Research proposal by the National Eye Institute (NEI), a division of the National Institutes of Health (NIH).

August 18, 2016 | Center to Host 6th Annual Southeastern Ocular Oncology/Pathology Seminar (SEOP) Emory Eye Center will host the sixth annual Southeastern Ocular Oncology/Pathology Seminar (SEOP) on Friday, Sept. 30, 2016, in the Eye Centers Learning Resources Center, Calhoun Auditorium, from 8 a.m. to 4p.m.

July 18, 2016 | Nine Eye Center Physicians Named Americas Top Doctors Nine Emory Eye Center ophthalmologists were selected from the Atlanta metropolitan region as Americas Top Doctors.

May 26, 2016 | Emory Eye Center Postdocs Honored at Emory Research Symposium Postdoctoral research scientists placed among the top honorees at 9th Annual Postdoctoral Research Symposium.

May 25, 2016 | Top Southeastern U.S. Vision Research Scientists Gather for Symposium on Retinal Degeneration Emory Eye Center co-hosts with CVNR AVRC Retinal Degeneration Symposium.

May 23, 2016 | Child Survivors of Eye Cancer Gather for RB Day Picnic The 18th Emory Eye Center Retinoblastoma (RB) Kids Day Picnic held on Saturday, May 7, 2016, in Decatur, GA.

May 16, 2016 | Researchers Honored at 2016 ARVO Annual Meeting Emory Eye Center researchers were leading scientific contributors to this year's ARVO Annual Meeting.

May 3, 2016 | $150,000 Gift from Alcon Foundation Establishes Global Ophthalmology FellowshipThe Alcon Foundation pledges $150,000 to establish a Global Ophthalmology Emory (GO-E) Fellowship.

National Geographic Channel, Breakthrough Fighting Pandemics.

Ocular Surgery News, "Ebola virus poses threat of ocular complications during convalescence."

BBC News, "When Ebola lingers: A survivor's story."

BBC Radio 5 Live Drive, BBC 5 Live Drive [at the 2:20 min. mark].

Read more:
Emory Eye Center

Read More...

Atlanta Ophthalmology Associates

September 12th, 2016 8:49 pm

< > iLASIK Experience new vision and a new outlook on life with iLasik

The doctors at Atlanta Ophthalmology have collectively performed more than 20,000 cataract surgeries. Together, they have created a Cataract Center of Excellence.

During cataract replacement, the most common surgical procedure in the country, the lens is removed and replaced with an artificial one called an intraocular lens or IOL.

In order for a person to see clearly, the light coming into the eye must be focused on the retina. The main focusing elements in the eye are the cornea and the lens.

To pre-register for an appointment, schedule an appointment, pay online, or refill your rx please create an account.

Atlanta Ophthalmology Associates is located in Atlanta, GA and offers an array of services in a comfortable, relaxed atmosphere. Our skilled doctors and friendly staff provide the highest quality eye care using the most sophisticated technology available. We are dedicated to helping every patient enjoy the best possible vision.

AOA is located in the Glenridge Medical Center at 5730 Glenridge Drive, Suite 120, Atlanta, Ga 30328. Patients will be met by an open, welcoming lobby where we will be conveniently located on the first floor. Free Handicapped parking is located in the front with a $3.00-$4.00 charge for parking in the rear of the building.

Laser refractive surgery for nearsightedness, farsightedness, and astigmatism.

A Gentle Eyelid Cleanser

See the original post:
Atlanta Ophthalmology Associates

Read More...

Molecular Genetics – mmrl.edu

September 12th, 2016 8:49 pm

Genetics seems rather intimidating, but in its purest sense it is rather simple.The basis of genetics is fairly simple: DNA => RNA => A Protein.

DNA, or deoxyribonucleic acid, (DNA) is a long molecule that contains our unique genetic code. Nearly every cell in a persons body has the same DNA. Most DNA is located in the cell nucleus (where it is called nuclear DNA), but a small amount of DNA can also be found in the mitochondria (where it is called mitochondrial DNA or mtDNA).

The information in DNA is stored as a code made up of four chemical bases: adenine (A), guanine (G), cytosine (C), and thymine (T). Human DNA consists of about 3 billionof these bases, and more than 99 percent of those bases are the same in every person. The order, or sequence, of these bases determines the information available for building and maintaining an organism.

DNA bases pair up with each other, A with T and C with G, to form units called base pairs. Each base is also attached to a sugar molecule and a phosphate molecule. Together, a base, sugar, and phosphate are called a nucleotide. Nucleotides are arranged in two long strands that form a spiral called a double helix. The structure of the double helix is somewhat like a ladder, with the base pairs forming the ladders rungs and the sugar and phosphate molecules forming the vertical sidepieces of the ladder.

Ribonucleic acid (RNA) is very similar to DNA, but differs in a few important structural details: RNA nucleotides contain ribose sugars while DNA contains deoxyribose and RNA uses predominantly uracil instead of thymine present in DNA. RNA is transcribed (synthesized) from DNA by enzymes called RNA polymerases and further processed by other enzymes. RNA serves as the template for translation of genes into proteins, transferring amino acids to the ribosome to form proteins, and also translating the transcript into proteins.

RNAs serve as the working set of blue prints for a gene. Each gene is read, and then the messenger RNAs are sent to the molecular factories (ribosomes) that build proteins. These factories read the blueprints and use the information to make the appropriate protein. When the cell no longer needs to make any more of that protein, the RNA blueprints are destroyed. but because the master copy in the DNA remains intact, the cell can always go back to the DNA and make more RNA copies when it needs more of the encoded protein.

An example would be the suns UV light activating the genes in your skin cells to tan you. The gene is read and the RNA takes the message or blueprint to the ribosomes where melanin, the protein that tans your skin, is made.

As we discussed, each gene is made up of a series of bases and those bases provide instructions for making a single protein. Any change in the sequence of bases may be considered a mutation. Most of the mutations are naturally-occurring. For example, when a cell divides, it makes a copy of its DNA and sometimes the copy is not quite perfect. That small difference from the original DNA sequence is a mutation.

Mutations can also be caused by exposure to specific chemicals, metals, viruses, and radiation. These have the potential to modify the DNA. This is not necessarily unnatural even in the most isolated and pristine environments, DNA breaks down. Nevertheless, when the cell repairs the DNA, it might not do a perfect job of the repair. So the cell would end up with DNA slightly different than the original DNA and hence, a mutation.

Some mutations have little or no effect on the protein, while others cause the protein not to function at all. Other mutations may create a new effect that did not exist before. Many diseases are a result of mutations in certain genes. One example is the gene for sickle cell anemia. The mutation causing the blood disorder sickle cell anemia is a single nucleotide substitution (A to T) in the base number 17 out of 438 As, Ts, Cs and Gs . By changing the amino acid at that point, the impact is that the red blood cells are no longer round, but sickle in shape and carry less oxygen.

Some of these changes occur in cells of the body such as in skin cells as a result of sun exposure. Fortunately these types of changes are not passed on to our children. However, other types of errors can occur in the DNA of cells that produce the eggs and sperm. These errors are called germ line mutations and can be passed from parent to child. If a child inherits a germ line mutation from their parents, every cell in their body will have this error in their DNA. Germ line mutations are what cause diseases to run in families, and are responsible for hereditary diseases.

Sudden cardiac death (SCD) is a widespread health problem with several known inherited causes. Inherited SCD generally occurs in healthy individuals who do not have other conventional cardiac risk factors. Mutations in the genes in charge of creating the electrical activity of the heart have been found to be responsible for most arrhythmias, among them Short QT Syndrome, Long QT Syndrome, Brugada Syndrome, Familial Bundle Branch Block, Sudden Infant Death Syndrome and Sudden Unexpected Death Syndrome.

As researchers discover the role genes play in disease, there will be more genetic tests available to help doctors make diagnoses and pinpoint the cause of the disease. For example, heart disease can be caused either by a mutation in certain genes, or by environmental factors such as diet or exercise to name a few.

Physicians can easily diagnose a person with heart disease once they present symptoms. However, physicians can not easily identify the cause of the heart disease is in each person. Thus, most patients receive the same treatment regardless of underlying cause of the disease.

In the future, a panel of genetic tests for heart disease might reveal the specific genetic factors that are involved in a given person. People with a specific mutation may be able to receive treatment that is directed to that mutation, thereby treating the cause of the disease, rather than just the symptoms.

The ultimate goal of the MMRLs Molecular Genetics Program is to identify the factors that are responsible for these diseases. This knowledge will facilitate the development ofgene-specific therapies and cures for arrhythmias and identify individuals at risk for sudden cardiac deaths.

With the addition of the Molecular Biology and Molecular Genetics programs, MMRL is now integrally involved in both basic and clinical research, and is among the relatively few institutions worldwide with a consistent and concerted focus on bridging basic and clinical science. With an eye toward designing specific treatments and cures for disease, the Laboratorys research has the potential to affect us all.

See more here:
Molecular Genetics - mmrl.edu

Read More...

Experimental stem cell therapy helps restore paralyzed man’s …

September 12th, 2016 8:45 pm

When Kris Boesens car fishtailed on a wet road, hitting a tree and slamming into a telephone poll, the 21-year-old never thought he would walk again. But results from an early-stage clinical trial using stem cells to restore movement have given the 21-year-old promise that his spinal cord injury may one day be reversed, Fox 5 Atlanta reported.

Boesen, of Bakersfield, California, qualified for the study at the Keck Medical Center of the University of Southern California (USC).

He was extremely excited about having an opportunity to try to do somethingto get better than he was at that point, Boesens father, Rodney Boesen, told the news station.

Doctors told the young man that hed likely never have movement or sensation below his neck, but the trial aimed to improve those functions.

In early April within two weeks to 30 day of Boesens injury neurosurgeon Charles Liu and his team injected 10 million stem cells, called AST-OPC1 cells, directly into his cervical spinal cord, Fox 5 Atlanta reported. Within two weeks, the effects of his accident began to improve.

"Patientswho suffer these disabilities want more than anything else to do something for themselves, says Dr. Liu, director of the USC Neurorestoration Center, told the news station. They want to be more independent, less dependent. It makes all of us appreciate how important it is that we can do these things."

Today, three months after receiving the therapy, Boesen can feed himself, use his cellphone and operate his motorized wheelchair, according to Fox 5 Atlanta. He also can write his name, and hug family and friends.

"If I was there and I was able to thank them, he told the news station.I would just tell them, Thank you for giving (me) my life back. Thank you for allowing me to live my life again."

Since the procedure, Boesen has been evaluated four times, and he will be monitored every four months.

Read more:
Experimental stem cell therapy helps restore paralyzed man's ...

Read More...

Color Blindness – Topic Overview – WebMD

September 11th, 2016 7:44 pm

Color blindness means that you have trouble seeing red, green, or blue or a mix of these colors. It's rare that a person sees no color at all.

Color blindness is also called a color vision problem.

A color vision problem can change your life. It may make it harder to learn and read, and you may not be able to have certain careers. But children and adults with color vision problems can learn to make up for their problems seeing color.

Most color vision problems are inherited (genetic) and are present at birth.

People usually have three types of cone cells in the eye. Each type senses either red, green, or blue light. You see color when your cone cells sense different amounts of these three basic colors. The highest concentration of cone cells are found in the macula, which is the central part of the retina .

Inherited color blindness happens when you don't have one of these types of cone cells or they don't work right. You may not see one of these three basic colors, or you may see a different shade of that color or a different color. This type of color vision problem doesn't change over time.

A color vision problem isn't always inherited. In some cases, a person can have an acquired color vision problem. This can be caused by:

The symptoms of color vision problems vary:

See the original post here:
Color Blindness - Topic Overview - WebMD

Read More...

Gene therapy – Better Health Channel

September 10th, 2016 2:45 pm

This type of therapy is called therapeutic gene therapy or the use of genes as medicine. It is an experimental form of treatment that is still being developed, but it has the potential to revolutionise treatment for all kinds of genetic conditions.

Gene therapy targets the faulty genes responsible for genetic diseases. Inheriting a faulty (mutated) gene can directly cause a wide range of disorders such as cystic fibrosis and haemophilia. It can also cause susceptibility to some cancers. Gene therapy can be used to replace a faulty gene with a healthy version or to introduce a new gene that can cure a condition or modify its effects. This type of gene therapy is called therapeutic gene therapy or the use of genes as medicine. It is an experimental form of treatment that is still in its infancy but has the potential to revolutionise treatment for all kinds of genetic diseases.

Inheriting one or both copies of a faulty gene can cause a wide range of conditions such as haemophilia and cystic fibrosis, and can also result in increased susceptibility to some cancers. Gene therapy targets the faulty genes responsible for a genetic condition. Gene therapy can be used to replace a faulty gene copy with a working version or to introduce a new gene that can cure a condition or modify its effects.

One promising technique is to put the working gene inside a harmless virus, which has had most of its own genes removed it has been deactivated. A virus that causes disease (such as the common cold) works by slipping into a cell, taking over its DNA and forcing it to produce more viruses. Similarly, a deactivated virus can enter the specific cell and deliver the working gene.

Other techniques involve using stem cells. These are immature cells that have the potential to develop into cells with different functions. In this technique, stem cells are manipulated in the laboratory to accept new genes that can then change their behaviour. For example, a gene might be inserted into a stem cell that could make it better able to survive chemotherapy. This would be of assistance to those patients who could benefit from further chemotherapy following stem cell transplantation.

To make sure that future generations of the persons family were not affected by the genetic condition, their germ cells would need to undergo gene therapy too. However, a complicated range of ethical issues, as well as technical problems, means that gene therapy of germ cells is only a remote possibility.

The majority of trials are being conducted in the US and Europe, with only a modest number initiated in other countries, including Australia (1.6%). Most trials focus on treating acquired conditions such as cancer and AIDS, although an increasing number of genetic conditions are being targeted.

The concern is that manipulating factors such as intelligence might be tried, once gene therapy becomes commonplace. Ordinary characteristics, such as shortness or average IQ, might then be considered subnormal.

Another concern is that gene therapy might only be available to the rich. The challenge for nations experimenting with gene therapy is to come up with workable, fair and ethical guidelines for its use.

This page has been produced in consultation with and approved by: Better Health Channel - (need new cp)

Last updated: May 2011

Content on this website is provided for education and information purposes only. Information about a therapy, service, product or treatment does not imply endorsement and is not intended to replace advice from your doctor or other registered health professional. Content has been prepared for Victorian residents and wider Australian audiences, and was accurate at the time of publication. Readers should note that, over time, currency and completeness of the information may change. All users are urged to always seek advice from a registered health care professional for diagnosis and answers to their medical questions.

Continue reading here:
Gene therapy - Better Health Channel

Read More...

Gene Therapy for Diseases | ASGCT – American Society of Gene & Cell Therapy

September 10th, 2016 2:45 pm

Gene Therapy for Diseases

Gene Therapy has made important medical advances in less than two decades. Within this short time span, it has moved from the conceptual stage to technology development and laboratory research to clinical translational trials for a variety of deadly diseases. Among the most notable advancements are the following:

Severe Combined Immune Deficiency (ADA-SCID) ADA-SCID is also known as the bubble boy disease. Affected children are born without an effective immune system and will succumb to infections outside of the bubble without bone marrow transplantation from matched donors. A landmark study representing a first case of gene therapy "cure," or at least a long-term correction, for patients with deadly genetic disorder was conducted by investigators in Italy. The therapeutic gene called ADA was introduced into the bone marrow cells of such patients in the laboratory, followed by transplantation of the genetically corrected cells back to the same patients. The immune system was reconstituted in all six treated patients without noticeable side effects, who now live normal lives with their families without the need for further treatment.

Chronic Granulomatus Disorder (CGD) CGD is a genetic disease in the immune system that leads to the patients' inability to fight off bacterial and fungal infections that can be fatal. Using similar technologies as in the ADA-SCID trial, investigators in Germany treated two patients with this disease, whose reconstituted immune systems have since been able to provide them with full protection against microbial infections for at least two years.

Hemophilia Patients born with Hemophilia are not able to induce blood clots and suffer from external and internal bleeding that can be life threatening. In a clinical trial conducted in the United States , the therapeutic gene was introduced into the liver of patients, who then acquired the ability to have normal blood clotting time. The therapeutic effect however, was transient because the genetically corrected liver cells were recognized as foreign and rejected by the healthy immune system in the patients. This is the same problem faced by patients after organ transplantation, and curative outcome by gene therapy might be achievable with immune-suppression or alternative gene delivery strategies currently being tested in preclinical animal models of this disease.

Other genetic disorders After many years of laboratory and preclinical research in appropriate animal models of disease, a number of clinical trials will soon be launched for various genetic disorders that include congenital blindness, lysosomal storage disease and muscular dystrophy, among others.

Cancer Multiple gene therapy strategies have been developed to treat a wide variety of cancers, including suicide gene therapy, oncolytic virotherapy, anti-angiogenesis and therapeutic gene vaccines. Two-thirds of all gene therapy trials are for cancer and many of these are entering the advanced stage, including a Phase III trial of Ad.p53 for head and neck cancer and two different Phase III gene vaccine trials for prostate cancer and pancreas cancer. Additionally, numerous Phase I and Phase II clinical trials for cancers in the brain, skin, liver, colon, breast and kidney among others, are being conducted in academic medical centers and biotechnology companies, using novel technologies and therapeutics developed on-site.

Neurodegenerative Diseases Recent progress in gene therapy has allowed for novel treatments of neurodegenerative diseases such as Parkinson's Disease and Huntington's Disease, for which exciting treatment results have been obtained in appropriate animal models of the corresponding human diseases. Phase I clinical trials for these neurodegenerative disorders have been, or will soon be, launched.

Other acquired diseases The same gene therapeutic techniques have been applied to treat other acquired disorders such as viral infections (e.g. influenza, HIV, hepatitis), heart disease and diabetes, among others. Some of these have entered, or will soon be entering, into early phase clinical trials.

Read the original here:
Gene Therapy for Diseases | ASGCT - American Society of Gene & Cell Therapy

Read More...

Gene Therapy – Biotechnology – Science and Research

September 10th, 2016 2:45 pm

Gene therapy is using "genes as medicine". It is an experimental approach to treating genetic disease where the faulty gene is fixed, replaced or supplemented with a healthy gene so that it can function normally. Most genetic diseases cannot be treated, but gene therapy research gives some hope to patients and their families as a possible cure. However, this technology does not come without risks and many clinical trials to evaluate its effectiveness need to be done before gene therapy can be put to regular medical use.

To get a new gene into a cell's genome, it must be carried in a molecule called a vector. The most common vectors currently being used are viruses, which naturally invade cells and insert their genetic material into that cell's genome. To use a virus as a vector, the virus' own genes are removed and replaced with the new gene destined for the cell. When the virus attacks the cell, it will insert the genetic material it carries. A successful transfer will result in the target cell now carrying the new gene that will correct the problem caused by the faulty gene.

Viruses that can be used as vectors include retroviruses like HIV, adenoviruses (one of which causes the common cold), adeno-associated viruses and herpes simplex viruses. There are also many non-viral vectors being tested for gene therapy uses. These include artificial lipid spheres called liposomes, DNA attached to a molecule that will bind to a receptor on the target cell, artificial chromosomes and naked DNA that is not attached to another molecule at all and can be directly inserted into the cell.

The actual transfer of the new gene into the target cell can happen in two ways: ex vivo and in vivo. The ex vivo approach involves transferring the new gene into cells that have been removed from the patient and grown in the laboratory. Once the transfer is complete, the cells are returned to the patient, where they will continue to grow and produce the new gene product. The in vivo approach delivers the vector directly to the patient, where transfer of the new gene will occur in the target cells within the body.

Conditions or disorders that result from mutations in a single gene are potentially the best candidates for gene therapy. However, the many challenges met by researchers working on gene therapy mean that its application is still limited while the procedure is being perfected.

Before gene therapy can be used to treat a certain genetic condition or disorder, certain requirements need to be met:

Clinical trials for gene therapy in other countries (for example France and the United Kingdom) have shown that there are still several major factors preventing gene therapy from becoming a routine way to treat genetic conditions and disorders. While the transfer of the new gene into the target cells has worked, it does not seem to have a long-lasting effect. This suggests that patients would have to be treated multiple times to control the condition or disorder. There is also always a risk of a severe immune response, since the immune cells are trained to attack any foreign molecule in the body. Working with viral vectors has proven to be challenging because they are difficult to control and the body immediately recognizes and attacks common viruses. Recent work has focussed on potential non-viral vectors to avoid the complications associated with the viral vectors. Finally, while there are thousands of single-gene disorders, the more common genetic disorders are actually caused by multiple genes, which do not make them good candidates for gene therapy.

One promising application of gene therapy is in treating type I diabetes. Researchers in the United States used an adenovirus as a vector to deliver the gene for hepatocyte growth factor (HGF) to pancreatic islet cells removed from rats. They injected the altered cells into diabetic rats and, within a day, the rats were controlling their blood glucose levels better than the control rats. This model mimics the transplantation of islet cells in humans and shows that the addition of the HGF gene greatly enhances the islet cells' function and survival.

In Canada, researchers in Edmonton, Alberta also developed a protocol to treat type I diabetes. Doctors use ultrasound to guide a small catheter through the upper abdomen and into the liver. Pancreatic islet cells are then injected through the catheter into the liver. In time, islets are established in the liver and begin releasing insulin.

Another application for gene therapy is in treating X-linked severe combined immunodeficiency (X-SCID), a disease where a baby lacks both T and B cells of the immune system and is vulnerable to infections. The current treatment is bone marrow transplant from a matched sibling, which is not always possible or effective in the long term. Researchers in France and the United Kingdom, knowing the disease was caused by a faulty gene on the X chromosome, treated 14 children by replacing the faulty gene ex vivo. Upon receiving the altered cells, the patients showed great improvements in their immune system functions. Unfortunately, two of the children developed a form of leukemia several years after the treatment. Further investigation showed that the vector had inserted the gene near a proto-oncogene, which led to uncontrolled growth of the T cells. The clinical trials were put on hold until a safer method can be designed and tested.

Excerpt from:
Gene Therapy - Biotechnology - Science and Research

Read More...

Gene Tierney – Wikipedia, the free encyclopedia

September 10th, 2016 2:45 pm

Gene Eliza Tierney (November 19, 1920 November 6, 1991)[3] was an American film and stage actress. Acclaimed as a great beauty, she became established as a leading lady.[4][5] Tierney was best known for her portrayal of the title character in the film Laura (1944), and was nominated for an Academy Award for Best Actress for her performance as Ellen Berent Harland in Leave Her to Heaven (1945).[6]

Tierney's other roles include Martha Strable Van Cleve in Heaven Can Wait (1943), Isabel Bradley Maturin in The Razor's Edge (1946), Lucy Muir in The Ghost and Mrs. Muir (1947), Ann Sutton in Whirlpool (1949), Maggie Carleton McNulty in The Mating Season (1951), and Anne Scott in The Left Hand of God (1955).

Tierney was born on November 19, 1920 in Brooklyn, New York, the daughter of Howard Sherwood Tierney and Belle Lavina Taylor. The family owned a brownstone at 900 St. Mark's Avenue, which was at the time a very fashionable street in the Crown Heights neighborhood of Brooklyn. She was named after a beloved uncle, who died young.[6][pageneeded] She had an elder brother, Howard Sherwood Butch Tierney, Jr., and a younger sister, Patricia Pat Tierney. Their father was a successful insurance broker of Irish descent, their mother a former physical education instructor.[6][pageneeded]

Tierney attended St. Margaret's School in Waterbury, Connecticut, and the Unquowa School in Fairfield. She published her first poem, entitled "Night", in the school magazine and wrote poetry occasionally throughout her life. Tierney played Jo in a student production of Little Women, based on the novel by Louisa May Alcott.

Tierney spent two years in Europe, attending Brillantmont International School in Lausanne, Switzerland, where she learned to speak fluent French. She returned to the U.S. in 1938 and attended Miss Porter's School in Farmington, Connecticut . On a family trip to the West Coast, she visited Warner Bros. studios, where a cousin worked as a producer of historical short films. director Anatole Litvak, taken by the 17-year-olds beauty, told her that she should become an actress. Warner Bros. wanted to sign her to a contract, but her parents advised against it because of the relatively low salary; they also wanted her in a higher social position.[6][pageneeded]

Tierney's society debut occurred on September 24, 1938, when she was 17 years old.[6][pageneeded] Soon bored with society life, she decided to pursue an acting career. Her father said, If Gene is to be an actress, it should be in the legitimate theatre.[7] Tierney studied acting at a small Greenwich Village acting studio in New York with Broadway director and actor Benno Schneider. She became a protge of Broadway producer-director George Abbott.[7][8]

In Tierney's first role on Broadway, she carried a bucket of water across the stage in What a Life! (1938). A Variety magazine critic declared, "Miss Tierney is certainly the most beautiful water carrier I've ever seen!" She also worked as an understudy in The Primrose Path (1938).

The following year, she appeared in the role of Molly O'Day in the Broadway production Mrs. O'Brien Entertains (1939).[6][pageneeded] The New York Times critic Brooks Atkinson wrote, "As an Irish maiden fresh from the old country, Gene Tierney in her first stage performance is very pretty and refreshingly modest."[6][pageneeded] That same year, Tierney appeared as Peggy Carr in Ring Two (1939) to favorable reviews. Theater critic Richard Watts, Jr. of the New York Herald Tribune wrote, "I see no reason why Miss Tierney should not have an interesting theatrical career that is, if cinema does not kidnap her away."[6][pageneeded]

Tierney's father set up a corporation, Belle-Tier, to fund and promote her acting career. Columbia Pictures signed her to a six-month contract in 1939. She met Howard Hughes, who tried unsuccessfully to seduce her. From a well-to-do family herself, she was not impressed by his wealth.[6][pageneeded] Hughes eventually became a lifelong friend.

After a cameraman advised Tierney to lose a little weight, she wrote Harper's Bazaar magazine for a diet, which she followed for the next 25 years. Tierney was initially offered the lead role in National Velvet, but production was delayed.[6][pageneeded] When Columbia Pictures failed to find Tierney a project, she returned to Broadway and starred as Patricia Stanley to critical and commercial success in The Male Animal (1940). In The New York Times, Brooks Atkinson wrote, "Tierney blazes with animation in the best performance she has yet given".[6][pageneeded] She was the toast of Broadway before her 20th birthday. The Male Animal was a hit, and Tierney was featured in Life magazine. She was also photographed by Harper's Bazaar, Vogue, and Collier's Weekly.[6][pageneeded]

Two weeks after The Male Animal opened, Darryl F. Zanuck, the head of 20th Century Fox, was rumored to have been in the audience. During the performance, he told an assistant to note Tierney's name. Later that night, Zanuck dropped by the Stork Club, where he saw a young lady on the dance floor. He told his assistant, "Forget the girl from the play. See if you can sign that one." It was Tierney. At first, Zanuck did not think she was the actress he had seen. Tierney was quoted (after the fact), saying: "I always had several different 'looks', a quality that proved useful in my career."[6][pageneeded][8]

Tierney signed with 20th Century-Fox[6][pageneeded] and her motion picture debut was in a supporting role as Eleanor Stone in Fritz Lang's western The Return of Frank James (1940), opposite Henry Fonda.

A small role as Barbara Hall followed in Hudson's Bay (1941) with Paul Muni and she co-starred as Ellie Mae Lester in John Ford's comedy Tobacco Road (also 1941), and played the title role in Belle Starr, Zia in Sundown, and Victoria Charteris (Poppy Smith) in The Shanghai Gesture. She played Eve in Son of Fury: The Story of Benjamin Blake (1942), as well as the dual role of Susan Miller (Linda Worthington) in Rouben Mamoulian's screwball comedy Rings on Her Fingers, and roles as Kay Saunders in Thunder Birds, and Miss Young in China Girl (all 1942).[citation needed]

Receiving top billing in Ernst Lubitsch's comedy Heaven Can Wait (1943), as Martha Strable Van Cleve, signaled an upward turn in Tierney's career. Tierney recalled during the production of Heaven Can Wait:

"Lubitsch was a tyrant on the set, the most demanding of directors. After one scene, which took from noon until five to get, I was almost in tears from listening to Lubitsch shout at me. The next day I sought him out, looked him in the eye, and said, 'Mr. Lubitsch, I'm willing to do my best but I just can't go on working on this picture if you're going to keep shouting at me.' 'I'm paid to shout at you', he bellowed. 'Yes', I said, 'and I'm paid to take it but not enough.' After a tense pause, Lubitsch broke out laughing. From then on we got along famously."[6][pageneeded]

Tierney starred in what became her best remembered role: the title role in Otto Preminger's film noir Laura (1944), opposite Dana Andrews. After playing Tina Tomasino in A Bell for Adano (1945), she played the jealous, narcissistic femme fatale Ellen Berent Harland in Leave Her to Heaven (1945), adapted from a best selling novel by Ben Ames Williams. Appearing with Cornel Wilde, Tierney won an Academy Award nomination for Best Actress. This was 20th Century-Fox' most successful film of the 1940s. It was cited by director Martin Scorsese as one of his favorite films of all time, and he assessed Tierney as one of the most underrated actresses of the Golden Era.[9]

Tierney then starred as Miranda Wells in Dragonwyck (1946), along with Walter Huston and Vincent Price. It was Joseph L. Mankiewicz' debut film as a director, In the same period, she starred as Isabel Bradley, opposite Tyrone Power, in The Razor's Edge (also 1946), an adaptation of W. Somerset Maugham's novel of the same name. Her performance was critically praised.[citation needed]

Tierney played Lucy Muir in Mankiewicz's The Ghost and Mrs. Muir (1947), opposite Rex Harrison.[10] The following year, she co-starred again with Power, this time as Sara Farley in the successful screwball comedy That Wonderful Urge (1948). As the decade came to a close, Tierney reunited with Laura director Preminger to star as Ann Sutton in the classic film noir Whirlpool (1949), co-starring Richard Conte and Jos Ferrer. She appeared in two other film noirs: Jules Dassin's Night and the City, shot in London, and Otto Preminger's Where the Sidewalk Ends (both 1950).[citation needed]

Tierney was loaned to Paramount Pictures, giving a comic turn as Maggie Carleton in Mitchell Leisen's ensemble farce, The Mating Season (1951), with John Lund, Thelma Ritter, and Miriam Hopkins.[6][pageneeded] She gave a tender performance as Midge Sheridan in the Warner Bros. film, Close to My Heart (1951), with Ray Milland. The film is about a couple trying to adopt a child.[6][pageneeded] Later in her career, she was reunited with Milland in Daughter of the Mind (1969).

After Tierney appeared opposite Rory Calhoun as Teresa in Way of a Gaucho (1952), her contract at 20th Century-Fox expired. That same year, she starred as Dorothy Bradford in Plymouth Adventure, opposite Spencer Tracy at MGM. She and Tracy had a brief affair during this time.[11] Tierney played Marya Lamarkina opposite Clark Gable in Never Let Me Go (1953), filmed in England.[6][pageneeded]

Tierney remained in Europe to play Kay Barlow in United Artists' Personal Affair (1953). While in Europe, she began a romance with Prince Aly Khan, but their marriage plans met with fierce opposition from his father Aga Khan III.[12] Early in 1953, Tierney returned to the U.S. to co-star in film noir Black Widow (1954) as Iris Denver, with Ginger Rogers and Van Heflin.

Tierney had reportedly started smoking after a screening of her first movie to lower her voice, because she felt, "Isound like an angry Minnie Mouse."[13] She subsequently became a heavy smoker.[13]

With difficult events in her personal life, Tierney struggled for years with episodes of manic depression. In 1943, she gave birth to a daughter, Daria, who was deaf and mentally disabled, the result of a fan breaking out of rubella quarantine and infecting the pregnant Tierney while she volunteered at the Hollywood Canteen. In 1953, she suffered problems with concentration, which affected her film appearances. She dropped out of Mogambo and was replaced by Grace Kelly.[6][pageneeded] While playing Anne Scott in The Left Hand of God (1955), opposite Humphrey Bogart, Tierney became ill. Bogart had a personal experience as he was close to a sister who suffered from mental illness, so during the production, he fed Tierney her lines and encouraged her to seek help.[6][pageneeded]

Tierney consulted a psychiatrist and was admitted to Harkness Pavilion in New York. Later, she went to the Institute of Living in Hartford, Connecticut. After some 27 shock treatments, intended to alleviate severe depression, Tierney fled the facility, but was caught and returned. She later became an outspoken opponent of shock treatment therapy, claiming it had destroyed significant portions of her memory.[citation needed]

In late December 1957, Tierney, from her mother's apartment in Manhattan, stepped onto a ledge 14 stories above ground and remained for about 20 minutes in what was considered a suicide attempt.[14] Police were called, and afterwards Tierney's family arranged for her to be admitted to the Menninger Clinic in Topeka, Kansas. The following year, after treatment for depression, she was released. Afterwards, she worked as a sales girl in a local dress shop with hopes of integrating back into society,[14] but she was recognized by a customer, resulting in sensational newspaper headlines.

Later in 1958, 20th Century-Fox offered Tierney a lead role in Holiday for Lovers (1959), but the stress upon her proved too great, so only days into production, she dropped out of the film and returned to Menninger for a time.[14]

Tierney made a screen comeback in Advise and Consent (1962), co-starring with Franchot Tone.[6][pageneeded] Soon afterwards, she played Albertine Prine in Toys in the Attic (1963), based on the play by Lillian Hellman. This was followed by the international production of Las cuatro noches de la luna llena, (Four Nights of the Full Moon - 1963), in which she starred with Dan Dailey. She received critical praise overall for her performances.[citation needed]

Tierney's career as a solid character actress seemed to be back on track as she played Jane Barton in The Pleasure Seekers (1964), but then she suddenly retired. She returned to star in the television movie Daughter of the Mind (1969) with Don Murray and Ray Milland. Her final performance was in the TV miniseries Scruples (1980).[6][pageneeded]

Tierney married two men: the first was Oleg Cassini, a costume and fashion designer, on June 1, 1941, with whom she eloped. Her parents opposed the marriage, as he was from a Russian-Italian family and born in France.[14] She had two daughters, Antoinette Daria Cassini (October 15, 1943 September 11, 2010)[15] and Christina "Tina" Cassini (November 19, 1948 March 31, 2015), born after their divorce, paternity of whom was the subject of intrigue and speculation at the time due to Tierney's links with Howard Hughes, Tyrone Power, John Fitzgerald Kennedy, and Charles Feldman.[16]

In June 1943, while pregnant with Daria, Tierney contracted rubella (German measles), likely from a fan ill with the disease.[14] Daria was born prematurely in Washington, DC, weighing three pounds, two ounces (1.42kg) and requiring a total blood transfusion. The rubella caused congenital damage: Daria was deaf, partially blind with cataracts, and severely mentally disabled. She was institutionalized for much of her life.[14] This was partial inspiration for the Agatha Christie novel The Mirror Crack'd from Side to Side.

Tierney's friend Howard Hughes paid for Daria's medical expenses, ensuring the girl received the best care. Tierney never forgot his acts of kindness.[6]

Tierney and Cassini separated October 20, 1946, and entered into a property settlement agreement November 10, 1946.[17] Periodicals during this period record Tierney with Charles K. Feldman,[18] including articles related to her "twosoming" with Feldman, her "current best beau".[19] An uncontested divorce followed in California; their final divorce decree was dated March 13, 1948. The Los Angeles Times reported that the couple reconciled on April 19, 1948, but did not remarry.[17]

During their separation, Tierney met John F. Kennedy, a young World War II veteran, who was visiting the set of Dragonwyck in 1946. They began a romance that she ended the following year after Kennedy told her he could never marry her because of his political ambitions.[11] In 1960, Tierney sent Kennedy a note of congratulations on his victory in the presidential election. During this time, newspapers documented Tierney's other romantic relationships, including Kirk Douglas.[20]

While filming for Personal Affair in Europe, she began a romance with Prince Aly Khan.[12] They became engaged in 1952, while Khan was going through a divorce from Rita Hayworth.[21] Their marriage plans, however, met with fierce opposition from his father, Aga Khan III.[12]

Cassini later bequeathed $500,000 in trust to Daria and $1,000,000 to Christina.[22][23] Cassini and Tierney remained friends until her death in November 1991.

In 1958, Tierney met Texas oil baron W. Howard Lee, who had been married to actress Hedy Lamarr since 1953. Lee and Lamarr divorced in 1960 after a long battle over alimony,[24] then Lee and Tierney married in Aspen, Colorado, on July 11, 1960. They lived quietly in Houston, Texas, and Florida[14] until his death in 1981.[24]

In 1960, 20th Century Fox announced Tierney would play the lead role in Return to Peyton Place, but she dropped out of the project after becoming pregnant. She later miscarried.[6][pageneeded]

Tierney's autobiography, Self-Portrait, in which she candidly discusses her life, career, and mental illness, was published in 1979.

Tierney's second husband, W. Howard Lee, died on February 17, 1981 after a long illness.[24]

In 1986, Tierney was honored alongside actor Gregory Peck with the first Donostia Lifetime Achievement Award at the San Sebastian Film Festival in Spain.[25]

Tierney has a star on the Hollywood Walk of Fame at 6125 Hollywood Boulevard.

Tierney died of emphysema on November 6, 1991 in Houston, thirteen days before her 71st birthday.[3] She is interred in Glenwood Cemetery in Houston. Tierney was survived by her daughters Daria and Christina. Certain documents of Tierney's film-related material, personal papers, letters, etc., are held in the Wesleyan University Cinema Archives, to which scholars, media experts, and the public may have access.[26]

Read the original post:
Gene Tierney - Wikipedia, the free encyclopedia

Read More...

Diabetes Causes – Mayo Clinic

September 10th, 2016 2:44 pm

To understand diabetes, first you must understand how glucose is normally processed in the body.

Insulin is a hormone that comes from a gland situated behind and below the stomach (pancreas).

Glucose a sugar is a source of energy for the cells that make up muscles and other tissues.

The exact cause of type 1 diabetes is unknown. What is known is that your immune system which normally fights harmful bacteria or viruses attacks and destroys your insulin-producing cells in the pancreas. This leaves you with little or no insulin. Instead of being transported into your cells, sugar builds up in your bloodstream.

Type 1 is thought to be caused by a combination of genetic susceptibility and environmental factors, though exactly what many of those factors are is still unclear.

In prediabetes which can lead to type 2 diabetes and in type 2 diabetes, your cells become resistant to the action of insulin, and your pancreas is unable to make enough insulin to overcome this resistance. Instead of moving into your cells where it's needed for energy, sugar builds up in your bloodstream.

Exactly why this happens is uncertain, although it's believed that genetic and environmental factors play a role in the development of type 2 diabetes. Being overweight is strongly linked to the development of type 2 diabetes, but not everyone with type 2 is overweight.

During pregnancy, the placenta produces hormones to sustain your pregnancy. These hormones make your cells more resistant to insulin.

Normally, your pancreas responds by producing enough extra insulin to overcome this resistance. But sometimes your pancreas can't keep up. When this happens, too little glucose gets into your cells and too much stays in your blood, resulting in gestational diabetes.

.

More:
Diabetes Causes - Mayo Clinic

Read More...

Types of Diabetes | NIDDK

September 9th, 2016 1:51 pm

Learn about Diabetes

You can learn how to take care of your diabetes and prevent some of the serious problems diabetes can cause. The more you know, the better you can manage your diabetes.

Share this booklet with your family and friends so they will understand more about diabetes. Also make sure to ask your health care team any questions you might have.

You can learn how to take care of your diabetes.

Diabetes is when your blood glucose, also called blood sugar, is too high. Blood glucose is the main type of sugar found in your blood and your main source of energy. Glucose comes from the food you eat and is also made in your liver and muscles. Your blood carries glucose to all of your bodys cells to use for energy.

Your pancreasan organ, located between your stomach and spine, that helps with digestionreleases a hormone it makes, called insulin, into your blood. Insulin helps your blood carry glucose to all your bodys cells. Sometimes your body doesnt make enough insulin or the insulin doesnt work the way it should. Glucose then stays in your blood and doesnt reach your cells. Your blood glucose levels get too high and can cause diabetes or prediabetes.

Over time, having too much glucose in your blood can cause health problems.

Prediabetes is when the amount of glucose in your blood is above normal yet not high enough to be called diabetes. With prediabetes, your chances of getting type 2 diabetes, heart disease, and stroke are higher. With some weight loss and moderate physical activity, you can delay or prevent type 2 diabetes. You can even return to normal glucose levels, possibly without taking any medicines.

The signs and symptoms of diabetes are

Some people with diabetes dont have any of these signs or symptoms. The only way to know if you have diabetes is to have your doctor do a blood test.

The three main types of diabetes are type 1, type 2, and gestational diabetes. People can develop diabetes at any age. Both women and men can develop diabetes.

Type 1 diabetes, which used to be called juvenile diabetes, develops most often in young people; however, type 1 diabetes can also develop in adults. In type 1 diabetes, your body no longer makes insulin or enough insulin because the bodys immune system, which normally protects you from infection by getting rid of bacteria, viruses, and other harmful substances, has attacked and destroyed the cells that make insulin.

Treatment for type 1 diabetes includes

Type 2 diabetes, which used to be called adult-onset diabetes, can affect people at any age, even children. However, type 2 diabetes develops most often in middle-aged and older people. People who are overweight and inactive are also more likely to develop type 2 diabetes.

Type 2 diabetes usually begins with insulin resistancea condition that occurs when fat, muscle, and liver cells do not use insulin to carry glucose into the bodys cells to use for energy. As a result, the body needs more insulin to help glucose enter cells. At first, the pancreas keeps up with the added demand by making more insulin. Over time, the pancreas doesnt make enough insulin when blood sugar levels increase, such as after meals. If your pancreas can no longer make enough insulin, you will need to treat your type 2 diabetes.

Treatment for type 2 diabetes includes

Gestational diabetes can develop when a woman is pregnant. Pregnant women make hormones that can lead to insulin resistance. All women have insulin resistance late in their pregnancy. If the pancreas doesnt make enough insulin during pregnancy, a woman develops gestational diabetes.

Overweight or obese women have a higher chance of gestational diabetes. Also, gaining too much weight during pregnancy may increase your likelihood of developing gestational diabetes.

Gestational diabetes most often goes away after the baby is born. However, a woman who has had gestational diabetes is more likely to develop type 2 diabetes later in life. Babies born to mothers who had gestational diabetes are also more likely to develop obesity and type 2 diabetes.

More information about diabetes and pregnancy is provided in the NIDDK health topic, What I need to know about Gestational Diabetes.

Over time, diabetes can lead to serious problems with your blood vessels, heart, nerves, kidneys, mouth, eyes, and feet. These problems can lead to an amputation, which is surgery to remove a damaged toe, foot, or leg, for example.

The most serious problem caused by diabetes is heart disease. When you have diabetes, you are more than twice as likely as people without diabetes to have heart disease or a stroke. With diabetes, you may not have the usual signs or symptoms of a heart attack. The best way to take care of your health is to work with your health care team to keep your blood glucose, blood pressure, and cholesterol levels in your target range. Targets are numbers you aim for.

Most people with diabetes get care from primary care providers, such as internists, family physicians, or pediatricians. A team of health care providers can also improve your diabetes care.

In addition to a primary care provider, your health care team may include

If diabetes makes you feel sad or angry, or if you have other problems that worry you, you should talk with a counselor or mental health professional. Your doctor or certified diabetes educator can help you find a counselor.

Talk with your doctor about what vaccines and immunizations, or shots, you should get to keep from getting sick. Preventing illness is an important part of taking care of your diabetes.

When you see members of your health care team, ask lots of questions. Prepare a list of questions before your visit. Be sure you understand everything you need to know about taking care of your diabetes.

Read the original:
Types of Diabetes | NIDDK

Read More...

FBIOX – Fidelity Select Biotechnology Portfolio | Fidelity …

September 9th, 2016 1:48 pm

Objective

Seeks capital appreciation.

Investing primarily in companies engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. Normally investing at least 80% of assets in securities of companies principally engaged in these activities. Normally investing primarily in common stocks.

Stock markets, especially foreign markets, are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Foreign securities are subject to interest rate, currency exchange rate, economic, and political risks. Focus funds can be more volatile because of their narrow concentration in a specific industry. The biotechnology industry can be significantly affected by patent considerations, intense competition, rapid technological change and obsolescence, and government regulation. The fund may have additional volatility because it can invest a significant portion of assets in securities of a small number of individual issuers.

This description is only intended to provide a brief overview of the mutual fund. Read the fund's prospectus for more detailed information about the fund.

Here is the original post:
FBIOX - Fidelity Select Biotechnology Portfolio | Fidelity ...

Read More...

BIOtechNow

September 9th, 2016 1:48 pm

BIO is undertaking an aggressive effort to promote the value of biopharmaceutical innovations and ensure that all patients have access to the drugs they need. A vital component of this campaign is holding insurers and their allies accountable for standing in the way of that access. For months, weve blown the whistle on their discriminatory practices, high cost-sharing and cost-shifting, and their blatant falsehoods on whats driving their premium increases, and today, were introducing a ReadMore>

Last week, the Washington Post published an article titled Alzheimers Drug Trial Sparks Optimism which highlighted new findings from a paper published in Nature. They shared exciting news of positive early trial results for a potential new Alzheimers treatment. Overall this is the best news that weve had in my 25 years doing Alzheimers clinical research and it brings new hope for patients and families most affected by the disease, said one of the studys ReadMore>

Before innovative therapies can start helping patients, successful matches between investors and entrepreneurs seeking to develop new medicines must occur. Without access to capital, potentially lifesaving drugs will exist only as ideas. Every fall investors looking for good prospects in the biotech sector gather at the BIO Investor Forum in San Franciscothe birthplace of biotechnology and home to over 1,600 life sciences companies. Many of these companies and others from around the country come to ReadMore>

Casey Whitaker, Communications Coordinator, Animal Agriculture Alliance | 09/08/2016

I have always been a perfectionist when it comes to my work, so its no surprise I found my passion in an industry that also strives for perfection. Animal agriculture never stops reaching for the highest quality of animal care, environmental stewardship and food safety possible. The industry strives for perfection, but also knows that perfection is hard to come by in agriculture because farmers, ranchers, veterinarians and all those involved in the farm-to-fork process ReadMore>

Hans Sauer, Deputy General Counsel, Intellectual Property, Legal, BIO | 09/07/2016

The topic of inter partes reviews (IPRs) has dominated conversation in patent circles for the last several years (see our archive for some of our past articles on the subject). As uncertainty grows in the biopharma community about IPR procedures and the future of innovation, BIO will make IPRs a major topic of discussion at our upcoming IP and Diagnostics Symposium (BIO IPDX) as well as BIOs IP Counsels Committee Meeting in November. An administrative ReadMore>

Read the original here:
BIOtechNow

Read More...

Type 1 Diabetes: American Diabetes Association

September 8th, 2016 11:46 pm

Share:

Type 1 diabetes is usually diagnosed in children and young adults, and was previously known as juvenile diabetes. Only 5% of people with diabetes have this form of the disease.

In type 1 diabetes, the body does not produce insulin. The body breaks down the sugars and starches you eat into a simple sugar called glucose, which it uses for energy. Insulin is a hormone that the body needs to get glucose from the bloodstream into the cells of the body. With the help of insulin therapy and other treatments, even young children can learn to manage their condition and live long, healthy lives.

There are many components to proper management of type 1 diabetes.

With type 1, its very important to balance your insulin doses with the food you eat and the activity that you do.

Diabetes is a disease that affects the whole family, especially when a child is diagnosed.

While the Associations priority is to improve the lives of all people impacted by diabetes, type 1 diabetes is a critical focus of the organization. More than one-third of our research portfolio is dedicated to projects relevant to type 1 diabetes.

Learn more about when, why and how insulin therapy works for people with type 1 and type 2 diabetes.

Make sure your child's school is prepared to handle diabetes.

An invaluable parenting tool, featuring the latest advances in diabetes care, plus parenting advice from diabetes experts. Learn to navigate through the normal activities of childhood and raise your kids to be strong, confident, and capable of managing their own diabetes care.

Watch for symptoms of hyperglycemia (high blood glucose) and learn how to treat it.

Treat hypoglycemia (sometimes called an insulin reaction) as soon as possible.

Work with your doctors to create the best treatment plan for you.

Exercise and physical activity are good for everyone and especially important for children with diabetes. Just remember to check blood glucose (blood sugar) often before and after exercise.

This two-page introduction to type 1 diabetes is in PDF format so you can download it, print it, and hand it out to patients.

Diabetes touches everyone, and finding a cure is personal and urgent.

We Can Help:

Enter your ZIP to find out whats going on near you.

See the original post:
Type 1 Diabetes: American Diabetes Association

Read More...

Food & Fitness for People With Diabetes

September 8th, 2016 11:46 pm

Share:

Eating well-balanced meals is an essential part of taking better care of yourself and managing diabetes. So is regular physical activity, which is especially important for people with diabetes and those at risk for diabetes. Balancing what you eat and your physical activity are key to managing diabetes.

Having diabetes should not prevent you from enjoying a wide variety of foods. You can learn how to eat healthful meals and include your favorite foods so you can thrive with diabetes.

Eating healthful meals is an essential part of managing diabetes. All of our recipes use healthful ingredients and cooking techniques. Try the recipes and our meal plans for healthier eating.

Manage or prevent type 2 diabetes by getting and staying active.

Learn how to lose weight in a healthy way and keep it off. Find the weight loss strategy that works best for you and start feeling better now.

Let us guide you with quick meal ideas, healthy snack choices and tips for eating out.

Learn the best and worst choices from each food group, so youll know what to focus on for meals and snacks.

How much and what type of carbohydrate containing foods you eat makes a difference in managing diabetes.

Diabetes touches everyone, and finding a cure is personal and urgent.

We Can Help:

Enter your ZIP to find out whats going on near you.

Sign up for Recipes for Healthy Living and you'll get free seasonal recipes all year round.

Visit link:
Food & Fitness for People With Diabetes

Read More...

BioHealth and Life Sciences – Maryland is Open for Business

September 8th, 2016 11:45 pm

CAREERS

To post job/internship opportunities, employers must email BioHealth.info@Maryland.gov a request to post a job/internship link which includes the link to the job description (including application instructions, and the point of contacts name, title, organization address, phone and email.)

CurrentOpenings:

Dont miss the nextindustry event! Check out our calendar for a list ofBio events.

Marylands colleges and universities offer dozens of biohealth technology certificate, two and four year and advanced degree, continuing education and specialized training programs in fields ranging from nanotechnology to biomedical engineering, biotechnology manufacturing to clinical trials project management. A sampling of life sciences related programs are listed below. For more questions, or specific training needs, please contact the Maryland Department of Commerces Office of BioHealth and Life Sciencesfor more information.

Four Year Colleges and Universities:

Community Colleges:

The continuing growth of Biotechnology companies is dependent upon the level of training and education and skills of their workers. Marylands colleges and universities not only offer a wealth of biotechnology education and training programs, but also most willcustomize training targeted to specific needs. A number of private and nonprofit organizations also offer training. These programs include:

Bio-Trac

Bio-Trac offers hands-on biotechnology training workshops that are ideal for bench and research scientists. Team-taught by active researchers at a graduate/post graduate level, Bio-Trac workshops focus on the latest relevant technologies in cell and molecular biology. Bio-Trac provides custom designed training programs for government, private and academic institutions as well as conducting 20+ offerings at the Montgomery College Bioscience Education Center in Germantown, MD.

BioTRAIN

Training modules developed with industry input from board with large industry representation. In addition to designing training modules based in industry input, BioTRAIN staff work closely with Montgomery Colleges other Biotechnology certificate degree and programs to place students.

Biotechnical Institute (BTI)

Free skill-based scientific training provided to qualified adult high school graduates who are unemployed or underemployed to become entry-level biotechnicians/lab techs. BTI partners with Baltimore CC and has a successful placement record.

The Foundation for Advanced Education in the Sciences (FAES)

An array of management and leadership development seminars and workshops provided to help the medical science and public health community to advance their professional knowledge. FAES offers 120+ courses in 12 departments.

Maryland Tech Connection (MTC), operated out of Anne Arundel Workforce Development Corporation

Biotechnology and IT training for long term unemployed blending industry-led training and work and learn strategies with strong job seeker wrap-around supports. The program serves 12 counties and the city of Baltimore, and includes 59 partners.

Companies looking to open their first office in Maryland have a wide variety of incubators (with lab space and without wet lab space)to choose from. Use our incubator search tool to find the right space for you. Several of the incubators are housed inresearch parks where they have ample room to grow and leverage the parks resources. Browse through Marylandsresearch parks for a snapshot of what is available.

See the article here:
BioHealth and Life Sciences - Maryland is Open for Business

Read More...

Biotech, Pharmaceutical, Medical Device, and Chemical …

September 8th, 2016 11:45 pm

<-- Manitboa Biotech Company Name

City

Annapolis

Annapolis

Annapolis

Baltimore

Baltimore

Baltimore

Baltimore

Baltimore

Baltimore

Baltimore

Baltimore

Baltimore

Baltimore

Baltimore

Bethesda

Bethesda

Bethesda

Clarksville

Cockeysville

Columbia

Columbia

Columbia

Columbia

Columbia

Columbia

Columbia

Columbia

Columbia

Elkridge

Frederick

Frederick

Fredrick

Frederick

Frederick

Frederick

Frederick

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Gaithersburg

Galena

Germantown

Germantown

Germantown

Germantown

Germantown

Glen Burnie

Hanover

Havre de Grace

Hunt Valley

Lexington Park

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Rockville

Savage

Silver Spring

Sparks

Sparks

See more here:
Biotech, Pharmaceutical, Medical Device, and Chemical ...

Read More...

Mtech Biotechnology Research and Education Program

September 8th, 2016 11:45 pm

MARYLAND TECHNOLOGY ENTERPRISE INSTITUTE

PATHS FOR MARYLAND ENTREPRENEURS & INNOVATORS

BIOTECHNOLOGY RESEARCH AND EDUCATION PROGRAM

Overview

Mtech's Biotechnology Research and Education Program (BREP) is the region's premier biotechnology, biopharmaceutical and biofuel research center, designed to bolster Maryland's burgeoning biotechnology industry. The program consists of two core facilities dedicated to providing supplemental research to academia, government and industry.

Bioprocessing Scale-Up Facility

(BSF)

The BSF offers a broad range of bioprocess scale-up and production services, including fermentation, cell culture, separation, purification and product analysis. The BSF's capabilities include up to 250-liter fermentations. Past clients have included Martek Biosciences, MedImmune, NIH, Digene, NIST, and the US Army. MORE >>>

Biopharmaceutical Advancement Facility (BAF)

The BAF specializes in the development of cell culture-based biopharmaceutical products. The facility's staff members offer extensive expertise in addressing challenging problems with the advancement of anchorage-dependent or suspension-adapted cell lines. MORE >>>

The Biotechnology Research and Education Program maintains strong links to the Clark School of Engineerings Fischell Department of Bioengineering which offers bachelors, masters and doctoral degree programs. The Clark School also offers a graduate certification in bioengineering.

Learn more about the Fischell Department of Bioengineering

BREP's expert staff offer customized training in many aspects of bioprocessing for Maryland biotech companies.

Productivity Enhancement: Biopharmaceutical Manufacturing Consulting

The most successful biomanufacturing companies utilize their resources efficiently. They bring products to market faster, meet production deadlines and minimize waste. The Biotechnology Research and Education Program's Productivity Enhancement consulting component applies improved manufacturing techniques to biomanufacturing.

BREP consultants' areas of expertise include facility design and layout, process optimization and load balancing, material handling, logistics, and cellular manufacturing. They can also help companies be more productive in:

BREP Staff utilize the following four-step approach for bio manufacturing consulting:

Companies planning a facility expansion or relocation can take advantage of the BREP staff's expert advice for contractor review, new equipment selection and floor layout design. Biotech team members can create computer simulations of the proposed facility to help companies evaluate alternative processing flows, while process development solutions can be tested in the BSF.

Perform higher, faster and more efficiently by employing BREP's Productivity Enhancement consulting services.

Ben Woodard

Director, Biotechnology Research and Education Program

tel. (301) 405-3909

fax. (301) 405-8213

woodard@umd.edu

Biotechnology Research and Education Program

Chemical and Nuclear Engineering Building #090

University of Maryland

College Park, MD 20740

2120 Potomac Bldg. 092

University of Maryland

College Park, MD 20742-3415

tel: 301.405.3906

fax: 301.403.4105

Sign Up For Updates

Read this article:
Mtech Biotechnology Research and Education Program

Read More...

Supercourse: Epidemiology, the Internet, and Global Health

September 8th, 2016 4:52 am

ABCDEFGHIJKLMNOPQRSTUVWXYZ

Academic research council

Achievements public health

Achievements public health

Acne therapeutic strategies

Acute coronary symptoms

Acute coronary syndromes

Adenoviridae and iridoviridae

Adherence hypertension treatment

Administration management medical organizations

Adolescent health risk behavior

Adolescents reproductive health

Adolescents reproductive health

Adverse drug reactions

Advocacy strategy planning

African sleeping sickness

Aids/ hiv current senario

Airborne contaminants

Air pollution armenia

Air pollution armenia

American heart association

Aminoglycosidearginine conjugates

Analytic epidemiology

Anaplasmosis taxonomic

Anemia family practice

Anger regulation interventions

Antimicrobial resistance

Antimicrobrial peptides

Antiretroviral agents

Assessing disease frequency

Assessment bioterrorism threat

Assessment nutritional

Assistive technology devices

Attack preparedness events

Avian influenza: zoonosis

Bacterial membrane vesicles

Bacterial vaginosis pregnancy

Bases of biostatistics

Behaviour medical sciences

Betaserk treatment stroke

Bias confounding chance

Bimaristans (hospitals) islamic

Binomial distribution

Biochemical system medicine

Biological challenges

Biological epidemiologic studies

Biostatistics

Biostatistics public health

Blood donors non-donors

Blood glucose normaization

Bmj triages manuscripts

Body fluid volume regulation

Bolonya declaration education

Bone marrow transplantation

Breast self examination

Bronchial asthma treatmen

Building vulnerability

Burden infectious diseases

Burnout in physicians

Cncer en mxico

Cancer survivorship research

Canine monocytic ehrlichiosis

Capability development

Capture-recapture techniques

Cardiology practice grenada

Cardiometabolic syndrome

Cardiopulmonary resuscitation

Cardio-respiratory illness

Cardiovascular disease

Cardiovascular disease black

Cardiovascular disease prevention

Cardiovascular diseases

Cardiovascular system

Carpal tunnel syndrome

Caseous lymphadenitis

Cause epidemiological approach

Central nervous system

Cervical cancer screening

Changing interpretations

Chemical weapon bioterrorism

Chemiosmotic paradigm

Chickenpox children pregnancy

Child health kazakhstan

Childhood asthma bedding.

Childhood asthma prevalence

Childhood diabetes mellitus

Childhood hearing impairment

Children september 11th attacks

China

Chinese herbal medicines

Chns hypertension control

Cholera global health

Cholesterol education program

Chronic disease management

Chronic fatigue syndrome

Chronic liver disease

Chronic lung diseases

Chronic noncommunicable diseases

Chronic obstructive pulmonary disease

Chronic pulmonary heart

Excerpt from:
Supercourse: Epidemiology, the Internet, and Global Health

Read More...

Page 1,091«..1020..1,0901,0911,0921,093..1,1001,110..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick